Ethex issues voluntary recall

Ethex Corporation has issued a voluntary recall on certain products, expanding it to the retail level. The company is taking this action as a precautionary measure because the products may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practice (cGMP).

The expanded recall includes the following products: 

-Morphine sulfate extended-release tablets 15mg, 30mg and 60mg
-Morphine sulfate immediate-release tablets 15mg and 30mg
-Dextroamphetamine sulfate tablets 5mg and 10mg
-Isosorbide mononitrate extended-release tablets 30mg, 60mg and 120mg
-Propafenone HCl tablets 150mg, 225mg and 300 mg.

For more information call (800) 748-1472 or visit www.kvpharmaceutical.com.